| MeSH term | MeSH ID | Detail |
|---|---|---|
| Colitis, Ulcerative | D003093 | 24 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Cholestasis | D002779 | 23 associated lipids |
| Birth Weight | D001724 | 23 associated lipids |
| Shock, Hemorrhagic | D012771 | 4 associated lipids |
| Gastrointestinal Hemorrhage | D006471 | 27 associated lipids |
| Tay-Sachs Disease | D013661 | 2 associated lipids |
| Fetal Resorption | D005327 | 15 associated lipids |
Taurodeoxycholic acid
Taurodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Taurodeoxycholic acid is associated with abnormalities such as Ischemia and Wiskott-Aldrich Syndrome. The involved functions are known as Cell Proliferation, Transcriptional Activation, Phosphorylation, Anabolism and Biochemical Pathway. Taurodeoxycholic acid often locates in Body tissue, Epithelium, Blood, Mucous Membrane and Hepatic. The associated genes with Taurodeoxycholic acid are NOX5 gene, GPBAR1 gene, NR1H4 gene and SLC33A1 gene. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid.
Cross Reference
Introduction
To understand associated biological information of Taurodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Taurodeoxycholic acid?
Taurodeoxycholic acid is suspected in Ischemia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Taurodeoxycholic acid
PubChem Associated disorders and diseases
What pathways are associated with Taurodeoxycholic acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Taurodeoxycholic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Taurodeoxycholic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Taurodeoxycholic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Taurodeoxycholic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Taurodeoxycholic acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Taurodeoxycholic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| van de Heijning BJ et al. | Membrane cholesterol content of cholesterol/phospholipid vesicles determines the susceptibility to both damage and protection by bile salts: implications for bile physiology. | 1997 | Eur J Gastroenterol Hepatol | pmid:9187880 |
| Rao YP et al. | Activation of protein kinase C alpha and delta by bile acids: correlation with bile acid structure and diacylglycerol formation. | 1997 | J. Lipid Res. | pmid:9458268 |
| Loria P et al. | Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans. | 1997 | Hepatology | pmid:9185744 |
| Wiedmann TS et al. | Ionization and solubilization of 4 alkyl benzoic acids and 4 alkyl anilines in sodium taurodeoxycholate solutions. | 1997 | Pharm. Res. | pmid:9434277 |
| Castelnovo P and Albanesi C | Determination of the enantiomeric purity of N-propionyl-6,7-dimethoxy-2-aminotetralin by cyclodextrin-modified micellar electrokinetic chromatography. | 1997 | Electrophoresis | pmid:9221889 |
| Riepl RL et al. | Mediators of exocrine pancreatic secretion induced by intraduodenal application of bile and taurodeoxycholate in man. | 1997 | Eur. J. Med. Res. | pmid:9049590 |
| Hu MS et al. | Paracellular phosphate absorption in rat colon: a mechanism for enema-induced hyperphosphatemia. | 1997 | Miner Electrolyte Metab | pmid:9058363 |
| Alvarez C et al. | The pancreatic duct epithelium in vitro: bile acid injury and the effect of epidermal growth factor. | 1997 | Surgery | pmid:9288155 |
| Roda A et al. | Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat. | 1998 | Hepatology | pmid:9462652 |
| Duan RD et al. | Effects of ursodeoxycholate and other bile salts on levels of rat intestinal alkaline sphingomyelinase: a potential implication in tumorigenesis. | 1998 | Dig. Dis. Sci. | pmid:9508530 |